Trial Profile
Observational Prospective stUdy of aZilsartan Medoxomil/ Chlorthalidone Compared With Irbesartan/hydrochlorothiaZide Combination Therapy in Patients With arteriaL Hypertension and obEsity in Routine Clinical Practice (PUZZLE).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Aug 2022
Price :
$35
*
At a glance
- Drugs Azilsartan medoxomil/chlortalidone (Primary) ; Irbesartan/hydrochlorothiazide (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- Acronyms PUZZLE
- 20 Jun 2022 Results reporting data for AZL-C on office, 24-hour brachial, central blood pressure and aortic stiffness parameters after 1 month, 3 months and 6 months visits presented at the 31st European meeting on hypertension and cardiovascular protection
- 14 Oct 2020 Status changed from active, no longer recruiting to completed.
- 02 Jan 2020 Planned End Date changed from 31 Jan 2020 to 31 Mar 2020.